| Positive Rankings |
Low Put/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.13 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 337. |
Debt-to-Equity
Syndax Pharmaceuticals rank is 709 |
Low vPut/Call
Syndax Pharmaceuticals has a low Put/Call ratio of 0.37 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Syndax Pharmaceuticals is ranked 803. |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Syndax Pharmaceuticals is ranked 854. |
Price-to-Book
Syndax Pharmaceuticals rank is 1330 |
Up EPS Surprise
Syndax Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings. |
| Negative Rankings |
Negative Net Margin
Syndax Pharmaceuticals rank is 97 |
Price-to-Sales
Syndax Pharmaceuticals rank is 162 |
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Syndax Pharmaceuticals is ranked 284. |
Negative ROE
Syndax Pharmaceuticals rank is 548 |
Negative ROA
Syndax Pharmaceuticals rank is 584 |
90 Day Loss
Syndax Pharmaceuticals rank is 763 |
10 Day Loss
Syndax Pharmaceuticals rank is 1526 |
